Star Imaging and Path Lab Ltd

Star Imaging and Path Lab Ltd

₹ 134 -5.67%
05 Sep 1:44 p.m.
About

Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]

Key Points

Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.

  • Market Cap 233 Cr.
  • Current Price 134
  • High / Low 151 / 123
  • Stock P/E 14.7
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 34.7 %
  • ROE 40.6 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.9%

Cons

  • Company has high debtors of 222 days.
  • Working capital days have increased from 43.5 days to 121 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
69 58 79 84
54 52 55 54
Operating Profit 15 6 23 29
OPM % 21% 10% 30% 35%
0 0 1 0
Interest 2 2 3 3
Depreciation 4 3 5 5
Profit before tax 9 1 16 21
Tax % 33% 35% 23% 26%
6 1 12 16
EPS in Rs 41.93 3.87 82.80 11.80
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 7%
TTM: 6%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 36%
TTM: 37%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 34%
Last Year: 41%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 2 2 2 14
Reserves 17 17 30 34
30 27 31 33
10 16 20 18
Total Liabilities 58 61 82 98
15 19 22 21
CWIP 0 0 0 0
Investments 0 0 0 0
43 42 60 77
Total Assets 58 61 82 98

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
14 5 18 -6
-4 -7 -7 -4
-7 -5 2 -0
Net Cash Flow 3 -7 13 -10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 85 110 152 222
Inventory Days
Days Payable
Cash Conversion Cycle 85 110 152 222
Working Capital Days 6 -13 23 121
ROCE % 6% 34% 35%

Shareholding Pattern

Numbers in percentages

4 Recently
Aug 2025
71.92%
1.18%
11.44%
15.47%
No. of Shareholders 1,025

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents